FDA Revokes Approval for Breast Cancer Drug

Posted November 18, 2011 by M. Miller

The F.D.A. is revoking its approval of the drug Avastin for breast cancer. This comes after concluding that it “has not been shown to be safe and effective for that use.”

Roche, the maker of Avastin, states it will remain an approved treatment for certain other types of cancer.

Current breast cancer patients have pleaded desperately for the approval to be retained, as they feel the treatment is keeping them alive.